Structure and function of RET in multiple endocrine neoplasia type 2

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Germline mutations in the RET proto-oncogene are the primary cause of multiple endocrine neoplasia type 2 (MEN2), a hereditary cancer syndrome.
• Twenty-five years of research have elucidated RET genetics, signaling, and cell biology, establishing genotype-phenotype correlations in MEN2.
• However, the structural and molecular mechanisms underlying RET tyrosine kinase activation and oncogenic deregulation remain incompletely understood.

Purpose of the Study:

• To review the current understanding of RET receptor structure and function.
• To highlight recent crystallographic and biochemical findings that elucidate the molecular basis of RET activation.
• To connect these structural insights with genotype-phenotype relationships in MEN2.

Main Methods:

• Review of recent scientific literature focusing on RET structural biology and biochemistry.
• Analysis of crystallographic data and biochemical assays related to RET kinase domain.
• Integration of structural findings with existing knowledge of RET genetics and MEN2 phenotypes.

Main Results:

• Recent structural and biochemical studies have revealed previously unrecognized mechanisms of RET tyrosine kinase activation.
• Specific molecular determinants and unexpected modes of action have been identified.
• These findings provide a more detailed atomic-level understanding of RET deregulation in MEN2.

Conclusions:

• Detailed structural and molecular insights are crucial for understanding RET kinase activation and oncogenic potential.
• This knowledge enhances our comprehension of genotype-phenotype correlations in MEN2.
• Future therapeutic strategies for MEN2 may benefit from targeting these newly elucidated structural and molecular mechanisms.